封面
市场调查报告书
商品编码
1528015

全球神经刺激设备市场

Neurostimulation Devices

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 163 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年,全球神经刺激设备市场预计将达到 132 亿美元

全球神经刺激设备市场预计 2023 年为 80 亿美元,预计到 2030 年将达到 132 亿美元,2023 年至 2030 年复合年增长率为 7.3%。脊髓刺激设备是本报告分析的细分市场之一,预计复合年增长率为 8.3%,到分析期结束时将达到 48 亿美元。在分析期间,深部脑部刺激器细分市场的复合年增长率预计为 7.5%。

美国市场预计将成长22亿美元,中国复合年增长率为11.9%

预计 2023 年美国神经刺激设备市场规模将达 22 亿美元。中国作为世界第二大经济体,预计2030年市场规模将达31亿美元,2023-2030年分析期间复合年增长率为11.9%。其他值得注意的区域市场包括日本和加拿大,在分析期间预计复合年增长率分别为 2.7% 和 7.6%。在欧洲,德国的复合年增长率预计为 4.2%。

全球神经刺激设备市场 - 主要趋势与驱动因素总结

什么是神经刺激设备以及它们为何重要?

神经刺激设备是一种先进的医疗技术,旨在透过电刺激改变神经系统的活动。这些设备用于治疗各种神经系统疾病和慢性疼痛,为传统治疗失败时提供了一种治疗选择。常见用途包括治疗慢性疼痛的脊髓刺激、治疗帕金森氏症等运动障碍的脑深部刺激以及治疗癫痫和忧郁症的迷走神经刺激。神经刺激设备的价值在于它们能够以微创方式提供标靶治疗,缓解患者的衰弱症状并改善生活品质。这些设备的准确性和有效性使其成为管理复杂神经系统疾病套件的重要组成部分。

科技进步如何改进神经刺激设备?

技术进步不断改进神经刺激设备的功能和应用。关键创新之一是闭合迴路系统的开发,该系统允许根据患者的生理反应即时自动调整刺激参数。这可以让您获得最佳的治疗效果,同时最大限度地减少副作用。电池技术的进步也促进了更耐用、更有效率的设备的开发,减少了更换电池的外科手术频率。此外,无线技术的整合允许远端监控和调整,为患者和医疗保健提供者增加便利性。微电子和生物材料研究正在开发更小、更隐密的植入,这些植入物侵入性更小,对患者来说更舒适。这些技术进步不仅提高了神经刺激设备的功能和易用性,而且还扩展了其在治疗更广泛疾病方面的潜在应用。

神经刺激市场有哪些新趋势与创新?

神经刺激市场正在见证一些将塑造其未来的新趋势和创新。一个重要的趋势是对个人化医疗的日益关注,其中神经刺激疗法根据个别患者独特的神经学特征根据其特定需求进行客製化。另一个重要的发展是神经刺激在非传统领域的广泛应用,例如忧郁症和焦虑症等精神疾病以及阿兹海默症神经退化性疾病的认知增强。人们对非侵入性神经刺激设备也产生了浓厚的兴趣,例如经颅磁刺激(TMS)和经皮神经电刺激(TENS),这些设备无需手术植入即可提供治疗效果。此外,使用人工智慧(AI)和机器学习演算法的神经刺激设备的进一步研究预计将进一步完善和增强治疗通讯协定,提供更有效和个人化的治疗方案。这些趋势凸显了神经刺激市场的动态和创新本质,其驱动力是不断追求改善患者治疗效果和扩大治疗可能性。

推动神经刺激设备市场成长的因素有哪些?

神经刺激设备市场的成长受到多种因素的推动。首先,慢性疼痛和神经病变的盛行率不断增加是重要的驱动因素。这是因为这些疾病通常需要长期治疗,而神经刺激设备可以提供这种治疗。闭合迴路系统和无线功能的开发等技术进步透过改善设备功能和患者依从性来推动市场成长。神经刺激在精神疾病和认知障碍治疗中的广泛应用正在创造新的市场机会。此外,向个人化医疗的转变,即根据患者个别需求量身定制治疗方法,正在推动对先进神经刺激解决方案的需求。监管部门的核准和优惠的报销政策也使这些先进的治疗方法更容易获得,从而推动了市场的扩张。此外,世界人口老化使得更容易罹患神经系统疾病和慢性疼痛,这也促使神经刺激设备的采用越来越多。最后,市场成长是由于医疗保健专业人员和患者对神经刺激作为一种可行的治疗选择的认识和接受程度不断提高而推动的,这使得神经刺激设备发挥越来越重要的作用。

受访企业范例(32家知名企业)

  • Boston Scientific Corporation
  • LivaNova PLC
  • Medtronic, Inc.
  • NeuroPace, Inc.
  • NeuroSigma, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP-1227

Global Neurostimulation Devices Market to Reach US$13.2 Billion by 2030

The global market for Neurostimulation Devices estimated at US$8.0 Billion in the year 2023, is expected to reach US$13.2 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2023-2030. Spinal Cord Stimulation Devices, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$4.8 Billion by the end of the analysis period. Growth in the Deep Brain Stimulation Devices segment is estimated at 7.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 11.9% CAGR

The Neurostimulation Devices market in the U.S. is estimated at US$2.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.1 Billion by the year 2030 trailing a CAGR of 11.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 7.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Neurostimulation Devices Market - Key Trends and Drivers Summarized

What Are Neurostimulation Devices and Why Are They Important?

Neurostimulation devices are sophisticated medical technologies designed to alter nervous system activity through electrical stimulation. These devices are used to treat a variety of neurological disorders and chronic pain conditions, offering a therapeutic option where traditional treatments may have failed. Common applications include spinal cord stimulation for chronic pain management, deep brain stimulation for movement disorders like Parkinson’s disease, and vagus nerve stimulation for epilepsy and depression. The significance of neurostimulation devices lies in their ability to provide targeted therapy with minimal invasiveness, offering patients relief from debilitating symptoms and improving their quality of life. The precision and effectiveness of these devices have made them a crucial component in the toolkit for managing complex neurological conditions.

How Are Technological Advancements Enhancing Neurostimulation Devices?

Technological advancements are continuously enhancing the capabilities and applications of neurostimulation devices. One of the major innovations is the development of closed-loop systems, which can automatically adjust stimulation parameters in real-time based on the patient's physiological responses. This ensures optimal therapeutic outcomes while minimizing side effects. Advances in battery technology have also led to longer-lasting and more efficient devices, reducing the frequency of surgical interventions for battery replacements. Furthermore, the integration of wireless technology allows for remote monitoring and adjustments, providing greater convenience for both patients and healthcare providers. Research into microelectronics and biocompatible materials has resulted in smaller, more discreet implants that are less invasive and more comfortable for patients. These technological strides not only improve the functionality and usability of neurostimulation devices but also expand their potential applications in treating a broader range of conditions.

What Are the Emerging Trends and Innovations in the Neurostimulation Market?

The neurostimulation market is witnessing several emerging trends and innovations that are set to shape its future. One significant trend is the increasing focus on personalized medicine, where neurostimulation therapies are tailored to the specific needs of individual patients based on their unique neurological profiles. Another important development is the growing application of neurostimulation in non-traditional areas such as psychiatric disorders, including depression and anxiety, and even for cognitive enhancement in neurodegenerative diseases like Alzheimer's. The market is also seeing a surge in interest for non-invasive neurostimulation devices, such as transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS), which offer therapeutic benefits without the need for surgical implantation. Additionally, ongoing research into the use of artificial intelligence (AI) and machine learning algorithms in neurostimulation devices promises to further refine and enhance treatment protocols, providing more effective and individualized therapy options. These trends highlight the dynamic and innovative nature of the neurostimulation market, driven by the constant quest to improve patient outcomes and expand therapeutic possibilities.

What Factors Are Driving the Growth in the Neurostimulation Devices Market?

The growth in the neurostimulation devices market is driven by several factors. Firstly, the increasing prevalence of chronic pain and neurological disorders is a significant driver, as these conditions often require long-term management that neurostimulation devices can provide. Technological advancements, such as the development of closed-loop systems and wireless capabilities, are propelling market growth by enhancing device functionality and patient compliance. The expanding applications of neurostimulation in treating psychiatric disorders and cognitive impairments are opening new market opportunities. Additionally, the shift towards personalized medicine, where treatments are tailored to individual patient needs, is driving demand for sophisticated neurostimulation solutions. Regulatory approvals and favorable reimbursement policies are also facilitating market expansion by making these advanced therapies more accessible. Furthermore, the aging global population, which is more susceptible to neurological and chronic pain conditions, is contributing to the increased adoption of neurostimulation devices. Finally, growing awareness and acceptance of neurostimulation as a viable therapeutic option among both healthcare providers and patients are fueling market growth, ensuring these devices play an increasingly vital role in managing complex medical conditions.

Select Competitors (Total 32 Featured) -

  • Boston Scientific Corporation
  • LivaNova PLC
  • Medtronic, Inc.
  • NeuroPace, Inc.
  • NeuroSigma, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Neurostimulation Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Neurological Disorders Spurs Growth in Neurostimulation Devices
    • Technological Advancements in Closed-Loop Systems Propel Market Expansion
    • Personalized Medicine Expands Addressable Market Opportunity for Tailored Neurostimulation Therapies
    • Non-Invasive Neurostimulation Devices Here's How They Drive Adoption
    • Integration of Wireless Technology Strengthens Business Case for Remote Monitoring and Adjustments
    • Growing Applications in Psychiatric Disorders Generates Demand for Advanced Neurostimulation Solutions
    • Aging Global Population Throws the Spotlight on Increased Neurostimulation Device Adoption
    • Artificial Intelligence and Machine Learning Accelerates Demand for Intelligent Neurostimulation Devices
    • Increasing Use in Cognitive Enhancement for Neurodegenerative Diseases Expands Market Reach
    • Rising Awareness and Acceptance Drives Adoption Among Healthcare Providers and Patients
    • Advances in Microelectronics and Biocompatible Materials Sustain Growth in Device Miniaturization
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neurostimulation Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neurostimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Spinal Cord Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Spinal Cord Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Spinal Cord Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Deep Brain Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Deep Brain Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Sacral Nerve Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Sacral Nerve Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Sacral Nerve Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Vagus Nerve Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Vagus Nerve Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Gastric Electric Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Gastric Electric Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Gastric Electric Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Epilepsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Parkinson's by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Parkinson's by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Parkinson's by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Urinary & Fecal Incontinence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Urinary & Fecal Incontinence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Urinary & Fecal Incontinence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Alzheimer's by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Alzheimer's by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Alzheimer's by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Neurostimulation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: France 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Italy 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 92: UK Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 95: UK Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: UK Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: UK 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 98: Spain Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Spain Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Spain 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 101: Spain Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Spain Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Spain 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 104: Russia Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Russia Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Russia 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 107: Russia Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Russia Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Russia 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of Europe 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Rest of Europe 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Neurostimulation Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Asia-Pacific 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Asia-Pacific 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 125: Australia Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Australia Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Australia 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 128: Australia Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Australia Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Australia 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • INDIA
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 131: India Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: India Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: India 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 134: India Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: India Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: India 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 137: South Korea Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: South Korea Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: South Korea 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 140: South Korea Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: South Korea Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: South Korea 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of Asia-Pacific Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of Asia-Pacific 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of Asia-Pacific Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of Asia-Pacific 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Neurostimulation Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Latin America 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 155: Latin America Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Latin America Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Latin America 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 158: Argentina Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Argentina Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Argentina 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 161: Argentina Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Argentina Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Argentina 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 164: Brazil Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Brazil Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Brazil 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 167: Brazil Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Brazil Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Brazil 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 170: Mexico Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Mexico Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Mexico 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 173: Mexico Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Mexico Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Mexico 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Rest of Latin America Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Rest of Latin America 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 179: Rest of Latin America Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Latin America Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Latin America 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Neurostimulation Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Middle East 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 188: Middle East Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Middle East Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Middle East 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 191: Iran Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Iran Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Iran 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 194: Iran Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Iran Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Iran 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 197: Israel Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Israel Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Israel 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 200: Israel Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Israel Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Israel 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Saudi Arabia Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Saudi Arabia 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 206: Saudi Arabia Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Saudi Arabia Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Saudi Arabia 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 209: UAE Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: UAE Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: UAE 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 212: UAE Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: UAE Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: UAE 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Rest of Middle East Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Rest of Middle East 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 218: Rest of Middle East Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Rest of Middle East Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Rest of Middle East 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • AFRICA
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 221: Africa Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Africa Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Africa 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 224: Africa Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Africa Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Africa 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION